Crinetics Pharmaceuticals (CRNX) Leases (2019 - 2025)
Historic Leases for Crinetics Pharmaceuticals (CRNX) over the last 7 years, with Q3 2025 value amounting to $41.1 million.
- Crinetics Pharmaceuticals' Leases fell 704.6% to $41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.1 million, marking a year-over-year decrease of 704.6%. This contributed to the annual value of $43.5 million for FY2024, which is 653.5% down from last year.
- Crinetics Pharmaceuticals' Leases amounted to $41.1 million in Q3 2025, which was down 704.6% from $41.9 million recorded in Q2 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' Leases peaked at $48.0 million during Q3 2023, and registered a low of $1.3 million during Q2 2023.
- In the last 5 years, Crinetics Pharmaceuticals' Leases had a median value of $2.2 million in 2021 and averaged $21.9 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 2616.38% in 2023, then surged by 349217.88% in 2024.
- Over the past 5 years, Crinetics Pharmaceuticals' Leases (Quarter) stood at $1.9 million in 2021, then dropped by 21.46% to $1.5 million in 2022, then surged by 3032.5% to $46.5 million in 2023, then decreased by 6.54% to $43.5 million in 2024, then decreased by 5.42% to $41.1 million in 2025.
- Its Leases stands at $41.1 million for Q3 2025, versus $41.9 million for Q2 2025 and $42.7 million for Q1 2025.